Efficacy and safety of fitusiran prophylaxis in people with haemophilia A or haemophilia B with inhibitors (ATLAS-INH): a multicentre, open-label, randomised phase 3 trial
Genzyme, a Sanofi Company
Guy Young; Alok Srivastava; Kaan Kavakli; Cecil Ross; Jameela Sathar; Chur-Woo You; Huyen Tran; Jing Sun; Runhui Wu; Stacey Poloskey; Zhiying Qiu; Salim Kichou; Shauna Andersson; Baisong Mei; Savita Rangarajan
Biostatistics & Programming, Sanofi, Bridgewater, NJ, USA.